1. Dr. Shatdal Chaudhary
Associate Professor
Department of Internal Medicine
Universal College of Medical Sciences,
Bhairahawa, Nepal
2. Definition
Chronic inflammation of meninges where Symptoms
lasting for four weeks or more duration
Symptoms can be constant, fluctuate or slowly
worsen
Clinical course can vary widely between patients
3. Five Categories of disease
Meningeal infection
Malignancy
Noninfectious inflammatory disorders
Chemical meningitis
Parameningeal infections
5. Spirochetes
Treponema pallidum
Disseminates during early infection
Serum and CSF VDRL typically positive
Lyme Meningitis
Typically late summer and early fall
Travel to endemic area
History consistent with erythema migrans
Leptospirosis
Meningeal symptoms develop in 50% of
patients during anicteric second stage of
illness
6. Mycobacterium Tuberculosis
Bacilli seed to the meninges creating tubercles called
“Rich foci”
Tubercles that rupture into subarachnoid space
causing meningitis
Cranial nerve palsies can occur
CN VI most frequently affected
Up to 40% in children
17. CSF Analysis
PMN predominate/ Lymph
Low Glucose
predominate/
Normal Glucose
Bacteria
-Actinomyces,
Listeria, Brucellosis
Mumps
LCM
NSAIDS
Sulfa
Behcet’s
Early Viral
Viral
CNS Malignancy
Endocarditis
Early Mycobacterium
Early Fungal
Lymph
predominate/
Low Glucose
Mycobacterium
Fungi
18. Specific CSF Analysis
Antigen testing
Cryptococcus neoformans, HSV, VZV, EBV, CMV,
VDRL
Significant inter- and intralab variability with PCRs
Cultures – if routine cultures negative may need 10-20
ml of CSF
Aerobic
Mycobacterial
Fungal
Cytology
20. Further Examinations
PPD
CXR
Retinal Exam
Echocardiogram
MRI
Rarely lead to specific diagnosis
Focal abnormalities may be useful if brain biopsy considered
Meningeal/Brain Biopsy
Particularly useful if focal on imaging
Progressive disease despite empiric therapy
21. Treatment according to Etiological Agent
Empiric Therapy
Antituberculous therapy
Antiviral Therapy
Steroids
Persistent negative cultures
Infectious etiology though unlikely
Trial of combination of ATT+Antifungal+Steroids